News
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...
The results Lilly is reporting for its oral pill come as another big drug company, Pfizer, has decided to discontinue its ...
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
A daily weight loss pill that works like breakthrough fat jab Ozempic could be available in the UK as early as next year.
Patients with obesity often report being shamed and stigmatized in medical settings. How can physicians address weight ...
Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and ...
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become household names in recent years, hailed as revolutionary ...
20h
inews.co.uk on MSNWho could take new weight-loss pill – and who should avoid itThe first daily weight-loss pill is expected to be available in the UK as soon as 2026 after a trial found it to be effective ...
Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...
A new weight-loss pill taken daily could compete with injections like Ozempic, research suggests. Patients, who all were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results